罗丹明 110,二(对甲苯磺酰基-L-甘氨酰-L-脯氨酰-L-精氨酰胺)
罗丹明 110,二(对甲苯磺酰基-L-甘氨酰-L-脯氨酰-L-精氨酰胺)
Invitrogen™

罗丹明 110,二(对甲苯磺酰基-L-甘氨酰-L-脯氨酰-L-精氨酰胺)

这种 Molecular Probes™ 罗丹明 110 (R110) 双酰胺衍生物是一种灵敏且具有选择性的底物,可用于检测溶液或活细胞内的蛋白酶。这些荧光底物包含与 R110’ 的每个氨基共价连接的氨基酸或肽了解更多信息
Have Questions?
货号数量
R221242 mg
货号 R22124
价格(CNY)
7,054.00
Each
添加至购物车
数量:
2 mg
价格(CNY)
7,054.00
Each
添加至购物车
这种 Molecular Probes™ 罗丹明 110 (R110) 双酰胺衍生物是一种灵敏且具有选择性的底物,可用于检测溶液或活细胞内的蛋白酶。这些荧光底物包含与 R110’ 的每个氨基共价连接的氨基酸或肽。酶促切割后,没有荧光的双酰胺底物首先转化为荧光单酰胺,然后转化为 R110,同时伴随着荧光强度的进一步增加。该底物可用于使用荧光计或荧光微孔板读数仪连续测定细胞提取物和纯化酶制剂中的酶活性,或可用于通过流式细胞分析或荧光显微镜进行细胞内蛋白酶检测及分析。

底物规格:
• 底物名称:(p-tosyl-Gly-Pro-Arg)2-R110
• 用于检测:凝血酶
• R110 产物的激发/发射波长:(498/521 nm)

R110 反应产物的性质
R110 切割产物具有与荧光素相似的光谱特性,使其与标准荧光素滤光片组兼容。由于 R110 的消光系数很大,因此具有极好的信号背景比。而且,与荧光素不同,罗丹明 110 反应产物的荧光强度在 3–9 pH 值范围内保持恒定。我们还提供了供您在检测中使用的 R110 参比标准品

我们将为您制备定制 R110 底物
如果您无法在我们的库存列表中找到需要的产品,我们将为您制备定制 R110 底物。我们的定制服务高效且保密,而且我们绝对保证质量。我们经过ISO 9001:2000认证。

有关这些产品的更多信息,请参阅《Molecular Probes™ 手册》中肽酶和蛋白酶检测—第 10.4 节

仅供科研使用。不可用于人或动物的治疗或诊断。
仅供科研使用。不可用于诊断程序。
规格
细胞渗透性细胞通透性
适用于(设备)荧光计、微孔板读数仪
数量2 mg
运输条件室温
底物胱天蛋白酶底物
检测方法荧光
形式实心
底物属性基于肽的底物
目标酶凝血酶
Unit SizeEach
内容与储存
在冰箱(-5 至 -30°C)中储存。

引用和文献 (9)

引用和文献
Abstract
Membrane-based, dry-reagent prothrombin time tests.
Authors:Zweig SE, Meyer BG, Sharma S, Min C, Krakower JM, Shohet SB
Journal:Biomed Instrum Technol
PubMed ID:8739001
The authors describe a prototype membrane-based, dry-reagent prothrombin time assay for whole blood. This system uses an asymmetric polysulfone membrane to separate plasma from red blood cells, and works with samples as small as 10 microliters. The membrane contains calcium and thromboplastin, and permits the reactions of the complete extrinsic ... More
A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay.
Authors:Kupcho K, Somberg R, Bulleit B, Goueli SA
Journal:Anal Biochem
PubMed ID:12758259
Protein kinases play an important role in many cellular processes and mediate cellular responses to a variety of extracellular stimuli. They have been identified by many pharmaceuticals as valid targets for drug discovery. Because of the large number of protein kinases, and the large number of compounds to be screened, ... More
A homogeneous, nonradioactive high-throughput fluorogenic protein phosphatase assay.
Authors:Kupcho K, Hsiao K, Bulleit B, Goueli SA
Journal:J Biomol Screen
PubMed ID:15140384
Protein phosphatases are critical components in cellular regulation; they do not only act as antioncogenes by antagonizing protein kinases, but they also play a positive regulatory role in a variety of cellular processes that require dephosphorylation. Thus, assessing the function of these enzymes necessitates the need for a robust, sensitive ... More
Nanoliter homogenous ultra-high throughput screening microarray for lead discoveries and IC50 profiling.
Authors:Ma H, Horiuchi KY, Wang Y, Kucharewicz SA, Diamond SL
Journal:Assay Drug Dev Technol
PubMed ID:15871692
Microfluidic technologies offer the potential for highly productive and low-cost ultra-high throughput screening and high throughput selectivity profiling. Such technologies need to provide the flexibility of plate-based assays as well as be less expensive to operate. Presented here is a unique microarray system (the Reaction Biology [Malvern, PA] DiscoveryDot), which ... More
Complement component factor B has thrombin-like activity.
Authors:
Journal:Biochem Biophys Res Commun
PubMed ID:33740660